Your browser doesn't support javascript.
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan.
Ishige, Takashi; Shimizu, Toshiaki; Watanabe, Kenji; Arai, Katsuhiro; Kamei, Koichi; Kudo, Takahiro; Kunisaki, Reiko; Tokuhara, Daisuke; Naganuma, Makoto; Mizuochi, Tatsuki; Murashima, Atsuko; Inoki, Yuta; Iwata, Naomi; Iwama, Itaru; Koinuma, Sachi; Shimizu, Hirotaka; Jimbo, Keisuke; Takaki, Yugo; Takahashi, Shohei; Cho, Yuki; Nambu, Ryusuke; Nishida, Daisuke; Hagiwara, Shin-Ichiro; Hikita, Norikatsu; Fujikawa, Hiroki; Hosoi, Kenji; Hosomi, Shuhei; Mikami, Yohei; Miyoshi, Jun; Yagi, Ryusuke; Yokoyama, Yoko; Hisamatsu, Tadakazu.
  • Ishige T; Department of Pediatrics, Gunma University Graduate School of Medicine, 3-39-22, Showa-Machi, Maebashi, Gunma, 371-8511, Japan. ishiget@gunma-u.ac.jp.
  • Shimizu T; Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Watanabe K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Arai K; Division of Gastroenterology, Center for Pediatric Inflammatory Bowel Disease, National Center for Child Health and Development, Tokyo, Japan.
  • Kamei K; Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
  • Kudo T; Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Kunisaki R; Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Tokuhara D; Department of Pediatrics, Wakayama Medical University, Wakayama, Japan.
  • Naganuma M; Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan.
  • Mizuochi T; Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
  • Murashima A; Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center of Child Health and Development, Tokyo, Japan.
  • Inoki Y; Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
  • Iwata N; Department of Infection and Immunology, Aichi Children's Health and Medical Center, Obu, Japan.
  • Iwama I; Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.
  • Koinuma S; Japan Drug Information Institute in Pregnancy, National Center of Child Health and Development, Tokyo, Japan.
  • Shimizu H; Division of Gastroenterology, Center for Pediatric Inflammatory Bowel Disease, National Center for Child Health and Development, Tokyo, Japan.
  • Jimbo K; Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Takaki Y; Department of Pediatrics, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
  • Takahashi S; Department of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
  • Cho Y; Department of Pediatrics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Nambu R; Division of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.
  • Nishida D; Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Hagiwara SI; Department of Pediatric Gastroenterology, Nutrition and Endocrinology, Osaka Women's and Children's Hospital, Osaka, Japan.
  • Hikita N; Department of Pediatrics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Fujikawa H; Division of Gastroenterology, Center for Pediatric Inflammatory Bowel Disease, National Center for Child Health and Development, Tokyo, Japan.
  • Hosoi K; Division of Gastroenterology, Tokyo Metro Children's Medical Center, Tokyo, Japan.
  • Hosomi S; Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
  • Mikami Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Miyoshi J; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
  • Yagi R; Department of Pediatrics, Gunma University Graduate School of Medicine, 3-39-22, Showa-Machi, Maebashi, Gunma, 371-8511, Japan.
  • Yokoyama Y; Department of Intestinal Inflammation Research, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
  • Hisamatsu T; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo, Japan.
J Gastroenterol ; 58(2): 135-157, 2023 02.
Article in English | MEDLINE | ID: covidwho-2174197
ABSTRACT
Immunosuppressive therapies can affect the immune response to or safety of vaccination in patients with inflammatory bowel disease (IBD). The appropriateness of vaccination should be assessed prior to the initiation of IBD treatment because patients with IBD frequently undergo continuous treatment with immunosuppressive drugs. This consensus was developed to support the decision-making process regarding appropriate vaccination for pediatric and adult patients with IBD and physicians by providing critical information according to the published literature and expert consensus about vaccine-preventable diseases (VPDs) [excluding cervical cancer and coronavirus disease 2019 (COVID-19)] in Japan. This consensus includes 19 important clinical questions (CQs) on the following 4 topics VPDs (6 CQs), live attenuated vaccines (2 CQs), inactivated vaccines (6 CQs), and vaccination for pregnancy, childbirth, and breastfeeding (5 CQs). These topics and CQs were selected under unified consensus by the members of a committee on intractable diseases with support by a Health and Labour Sciences Research Grant. Physicians should provide necessary information on VPDs to their patients with IBD and carefully manage these patients' IBD if various risk factors for the development or worsening of VPDs are present. This consensus will facilitate informed and shared decision-making in daily IBD clinical practice.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Adult / Child / Female / Humans / Pregnancy Country/Region as subject: Asia Language: English Journal: J Gastroenterol Journal subject: Gastroenterology Year: 2023 Document Type: Article Affiliation country: S00535-022-01953-w

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Adult / Child / Female / Humans / Pregnancy Country/Region as subject: Asia Language: English Journal: J Gastroenterol Journal subject: Gastroenterology Year: 2023 Document Type: Article Affiliation country: S00535-022-01953-w